mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.093 |
0.04 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.04 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.04 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |